These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9419523)

  • 1. Intravenous manganese-mesoporphyrin as a magnetic resonance imaging contrast agent: an experimental model using VX-2 carcinoma in rabbits.
    Robinson DH; Schmiedl UP; Starr FL; Nelson JA; Malek R
    Acad Radiol; 1995 Jan; 2(1):43-9. PubMed ID: 9419523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the hepatobiliary system: intestinal absorption studies of manganese mesoporphyrin.
    Schmiedl UP; Nelson JA; Teng L; Starr F; Malek R; Ho RJ
    Acad Radiol; 1995 Nov; 2(11):994-1001. PubMed ID: 9419672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings.
    Ni Y; Marchal G; Yu J; Lukito G; Petré C; Wevers M; Baert AL; Ebert W; Hilger CS; Maier FK
    Acad Radiol; 1995 Aug; 2(8):687-99. PubMed ID: 9419626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical properties, biodistribution, and imaging characteristics of manganese-mesoporphyrin. A potential hepatobiliary contrast agent for magnetic resonance imaging.
    Schmiedl UP; Nelson JA; Robinson DH; Michalson A; Starr F; Frenzel T; Ebert W; Schuhmann-Giampieri G
    Invest Radiol; 1993 Oct; 28(10):925-32. PubMed ID: 8262747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic enhancement features of gadophrin-2 on magnetic resonance imaging: an experimental model of VX2 carcinoma and bacterial abscess in rabbit thigh.
    Ju Lee H; Kim IO; Kim TK; Hyung Kim S; Choi JI; Woo Lee J; Kyung Moon W; Choi BI; Chung Han M; Weinmann HJ; Hyun Chang K
    Invest Radiol; 2002 Dec; 37(12):663-71. PubMed ID: 12446999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of Mn-mesoporphyrin in a small bowel sac system: effect of oleic acid.
    von Ingersleben G; Schmiedl UP; Dong P; Nelson JA; Starr F; Ho RJ
    Acad Radiol; 1997 May; 4(5):355-60. PubMed ID: 9156232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver.
    Wisner ER; Merisko-Liversidge E; Kellar K; Katzberg RW; Karpinski PH; Amparo EG; Drake C; Griffey SM; Brock JM
    Acad Radiol; 1995 Feb; 2(2):140-7. PubMed ID: 9419538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium mesoporphyrin as an MR imaging contrast agent in the evaluation of tumors: an experimental model of VX2 carcinoma in rabbits.
    Kim TK; Choi BI; Park SW; Lee W; Han JK; Han MC; Weinmann HJ
    AJR Am J Roentgenol; 2000 Jul; 175(1):227-34. PubMed ID: 10882277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
    Young SW; Bradley B; Muller HH; Rubin DL
    Magn Reson Imaging; 1990; 8(3):267-76. PubMed ID: 2114511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
    Runge VM
    Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
    Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
    J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI.
    Marchal G; Ni Y; Herijgers P; Flameng W; Petré C; Bosmans H; Yu J; Ebert W; Hilger CS; Pfefferer D; Semmler W; Baert AL
    Eur Radiol; 1996; 6(1):2-8. PubMed ID: 8797942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Sugiyama M; Takeda H; Saga T; Nakajima S; Sakata I
    Magn Reson Med; 2002 Mar; 47(3):549-53. PubMed ID: 11870842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.